Viewing Study NCT05018403


Ignite Creation Date: 2025-12-24 @ 7:39 PM
Ignite Modification Date: 2025-12-30 @ 6:05 AM
Study NCT ID: NCT05018403
Status: COMPLETED
Last Update Posted: 2022-01-12
First Post: 2021-08-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: First-in-human Trial With Single-dose C5a-neutralizing AON-D21 in Healthy Male Subjects
Sponsor: Aptarion Biotech AG
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module